Martin is a founder of Vulpes Investment Management, a Cayman Fund Manager which currently manages five funds including the Vulpes Life Sciences Fund, Chronos Therapeutics’ largest shareholder.

An investment professional with over 29 years’ experience in investment banking and fund management, Martin has extensive, first-hand knowledge of the global financial markets.

Martin has been an investor in life sciences and biotechnology since 1999 and has developed a passionate interest in the sector having worked closely with several companies as a stakeholder over the past decade.